1. CXCR2 inhibition enables NASH-HCC immunotherapy. Issue 10 (27th April 2022) Authors: Leslie, Jack; Mackey, John B G; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; Pinyol, Roser; Esteban-Fabró, Roger; Willoughby, Catherine E; Haber, Philipp K; Andreu-Oller, Carmen; ... Journal: Gut Issue: Volume 71:Issue 10(2022) Page Start: 2093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗